Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CNS Pharmaceuticals Inc.

    NASDAQ: CNSP · Real-Time Price · USD
    1.04
    0.03 (2.97%)
    At close: Jun 06, 2025, 3:58 PM
    1.04
    0.01%
    After-hours: Jun 06, 2025, 05:46 PM EDT

    CNS Pharmaceuticals Statistics

    Share Statistics

    CNS Pharmaceuticals has 5.46M shares outstanding. The number of shares has increased by 0.2% in one year.

    Shares Outstanding

    n/a
    		 5.46M

    Shares Change (YoY)

    n/a
    		 0.2%

    Shares Change (QoQ)

    n/a
    		 30.66%

    Owned by Institutions (%)

    n/a
    		 3.2%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 731.73K, so 13.4% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 731.73K

    Short % of Shares Out

    n/a
    		 13.4%

    Short % of Float

    n/a
    		 13.4%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -1.55 and the forward PE ratio is -0.77. CNS Pharmaceuticals's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 -1.55

    Forward PE

    n/a
    		 -0.77

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 3.73

    P/FCF Ratio

    n/a
    		 -1.34

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for CNS Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.43, with a Debt / Equity ratio of 0.05.

    Current Ratio

    n/a
    		 3.43

    Quick Ratio

    n/a
    		 3.43

    Debt / Equity

    n/a
    		 0.05

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.02

    Interest Coverage

    n/a
    		 -924.5

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-3,714,450.25

    Employee Count

    n/a
    		 4

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 0.78, so CNS Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.78

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 1.13

    200-Day Moving Average

    n/a
    		 4.52

    Relative Strength Index (RSI)

    n/a
    		 39.81

    Average Volume (20 Days)

    n/a
    		 n/a

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -3.31K

    Operating Income

    n/a
    		 -14.9M

    Net Income

    n/a
    		 -14.86M

    EBITDA

    n/a
    		 -14.9M

    EBIT

    n/a
    		 -14.87M

    Earnings Per Share (EPS)

    n/a
    		 -38.87
    Full Income Statement

    Balance Sheet

    The company has 6.46M in cash and 326.07K in debt, giving a net cash position of 6.14M.

    Cash & Cash Equivalents

    n/a
    		 6.46M

    Total Debt

    n/a
    		 326.07K

    Net Cash

    n/a
    		 6.14M

    Retained Earnings

    n/a
    		 -84.42M

    Total Assets

    n/a
    		 13.75M

    Working Capital

    n/a
    		 10.94M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -17.11M and capital expenditures -4.19K, giving a free cash flow of -17.12M.

    Operating Cash Flow

    n/a
    		 -17.11M

    Capital Expenditures

    n/a
    		 -4.19K

    Free Cash Flow

    n/a
    		 -17.12M

    FCF Per Share

    n/a
    		 -4.48
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    CNSP does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for CNSP.

    Price Target

    n/a
    		 $25

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Feb 21, 2025. It was a backward split with a ratio of 1:50.

    Last Split Date

    n/a
    		 Feb 21, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:50

    Scores

    Altman Z-Score

    n/a
    		 -10.6

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist